{"filing":{"accession_number":"0001493152-26-032086","cik":"0001826397","ticker":"AVX","company_name":"AVAX ONE TECHNOLOGY LTD.","form":"8-K","filing_date":"2026-07-06","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1826397/000149315226032086/form8-k.htm"},"events":[{"id":16141,"run_id":14404,"accession_number":"0001493152-26-032086","anchor_item_number":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Jolie Kahn departed as Chief Executive Officer effective July 3, 2026, with no disagreement or removal for cause. While the filing also discloses Peter Wylie's appointment as interim CEO and compensatory arrangements (including a $40,000/month increase and Kahn's $250,000 equity grant), the principal disclosed action centers on the CEO's departure. The appointment of an interim successor is secondary to the departure event itself.","company_name":"AVAX ONE TECHNOLOGY LTD.","ticker":"AVX","filing_date":"2026-07-06","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":14144,"accession_number":"0001493152-26-032086","item_number":null,"item_title":null,"event_type":"exec_departure","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"Jolie Kahn departed as Chief Executive Officer effective July 3, 2026, with no disagreement or removal for cause. While the filing also discloses Peter Wylie's appointment as interim CEO and compensatory arrangements (including a $40,000/month increase and Kahn's $250,000 equity grant), the principal disclosed action centers on the CEO's departure. The appointment of an interim successor is secondary to the departure event itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-06T12:32:22.507808+00:00","company_name":"AVAX ONE TECHNOLOGY LTD.","ticker":"AVX","filing_date":"2026-07-06"}]}